Retrospective Study of the Linear™ Hip

February 8, 2011 updated by: Encore Medical, L.P.

Post-Market Study of the Linear™ Hip System

The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Florida
      • Vero Beach, Florida, United States, 32960
        • Hussamy Orthopedics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals who meet the indications for use of the Linear Hip device AND who meet the inclusion/exclusion criteria

Description

Inclusion Criteria:

  • Have hip joint disease related to one or more of the following

    • osteoarthritis
    • rheumatoid arthritis
    • femoral fracture
    • correction of a functional deformity
    • avascular necrosis of the natural femoral head
  • Skeletal maturity
  • Patient is likely to be available for evaluation for the duration of the study
  • Able and willing to sign the informed consent and follow study procedures
  • Patient is not pregnant
  • No infection present
  • No known materials sensitivity
  • Patient is over 18 years of age

Exclusion Criteria:

  • Skeletal immaturity
  • Infection or sepsis
  • Insufficient bone quality that may affect the stability of the implant
  • Muscular, neurologic or vascular deficiencies which compromise the affected extremity
  • Alcoholism or other addictions
  • Prisoners
  • High levels of physical activity
  • Patient is pregnant
  • Loss of ligamentous structures
  • Materials sensitivity
  • Patient is under 18 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Linear Hip
Encore Linear Hip System
Device: Encore Linear™ Hip System
Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis, have received the hip system and are willing to participate in the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The use and efficacy of the Encore Linear™ Hip System
Time Frame: 2 year
2 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Encore Medical, L.P.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2007

Primary Completion (Actual)

February 1, 2011

Study Completion (Actual)

February 1, 2011

Study Registration Dates

First Submitted

September 30, 2008

First Submitted That Met QC Criteria

October 1, 2008

First Posted (Estimate)

October 2, 2008

Study Record Updates

Last Update Posted (Estimate)

February 9, 2011

Last Update Submitted That Met QC Criteria

February 8, 2011

Last Verified

February 1, 2011

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PS - 800

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Femoral Fracture

Clinical Trials on Encore Linear™ Hip System

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe